Holen Sie sich die Stockscreener-App
1.91
0.00%
0.00
Schlusskurs vom Vortag:
$1.91
Offen:
$1.91
24-Stunden-Volumen:
70,340
Relative Volume:
0.58
Marktkapitalisierung:
$80.93M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-1.819
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
-8.61%
1M Leistung:
-10.12%
6M Leistung:
-26.54%
1J Leistung:
-32.27%
1-Tages-Spanne:
$1.84
$1.92
1-Wochen-Bereich:
$1.84
$2.10
52-Wochen-Spanne:
$1.59
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.91 | 80.93M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Is InspireMD Inc. (II2) stock supported by strong fundamentalsWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
Financial Contrast: InspireMD (NYSE:NSPR) vs. Biostage (OTCMKTS:BSTG) - Defense World
Will InspireMD Inc. (II2) stock profit from fiscal stimulusWeekly Gains Report & Risk Managed Investment Entry Signals - BỘ NỘI VỤ
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Yahoo Finance
InspireMD (NYSE:NSPR) Shares Up 2%Should You Buy? - MarketBeat
InspireMD announces publication of CREST-2 data in NEJM - TipRanks
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
InspireMD Celebrates Positive Outcomes from CREST-2 Study Supporting Carotid Stenting for Asymptomatic Patients - Quiver Quantitative
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - The Manila Times
Landmark CREST-2 Study Published in the New England Journal - GlobeNewswire
InspireMD announces inducement grants - Medical Buyer
InspireMD (Nasdaq: NSPR) Showcases CREST-2 NEJM Data on Lower Stroke Risk with CAS - Stock Titan
InspireMD Reports Record Revenue Amid U.S. Launch - MSN
What analysts say about InspireMD Inc stockMarket Correction Analysis & Low Entry Cost Trading - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD (Nasdaq: NSPR) grants 122,054 inducement shares to eight new hires - Stock Titan
What catalysts could drive InspireMD Inc. stock higherEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Is InspireMD Inc. (II2) stock suitable for passive index fundsOil Prices & Capital Protection Trade Alerts - newser.com
Can InspireMD Inc. (II2) stock survive global slowdownFed Meeting & Growth Focused Stock Pick Reports - newser.com
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Why analysts remain bullish on InspireMD Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Applying sector rotation models to InspireMD Inc.Quarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
InspireMD (NASDAQ: NSPR) schedules fireside chat at Piper Sandler healthcare conference - Stock Titan
How InspireMD Inc. (II2) stock responds to job market shifts2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Applying chart zones and confluence areas to InspireMD Inc.2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Is InspireMD Inc. stock poised for growthPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
NSPR SEC FilingsInspiremd 10-K, 10-Q, 8-K Forms - Stock Titan
How InspireMD Inc. stock reacts to Fed rate cuts2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
How strong dollar benefits InspireMD Inc. (II2) stockJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
What margin trends mean for InspireMD Inc. stockEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Short interest data insights for InspireMD Inc.Market Trend Summary & Consistent Income Trade Ideas - newser.com
InspireMD Q3 2025 Earnings Preview - MSN
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.89%
4.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):